Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

Hong Kong · Delayed Price · Currency is HKD

24.00

+0.28 (1.18%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Sales of Neurovascular and Peripheral-Vascular Interventional Surgical Devices	1.06B	782.48M	527.75M	334.09M	177.91M
Sales of Neurovascular and Peripheral-Vascular Interventional Surgical Devices Growth	35.15%	48.27%	57.97%	87.78%	543.89%
Total	1.06B	782.48M	527.75M	334.09M	177.91M
Total Growth	35.15%	48.27%	57.97%	87.78%	543.89%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
The PRC	1.01B	759.90M	513.48M	326.29M	174.45M
The PRC Growth	32.76%	47.99%	57.37%	87.04%	618.37%
Others	48.65M	22.58M	14.27M	7.80M	3.46M
Others Growth	115.47%	58.19%	83.07%	125.19%	3.44%
Total	1.06B	782.48M	527.75M	334.09M	177.91M
Total Growth	35.15%	48.27%	57.97%	87.78%	543.89%

Source: S&P Global Market Intelligence.